These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38884347)

  • 1. Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths.
    ; Samet JH; El-Bassel N; Winhusen TJ; Jackson RD; Oga EA; Chandler RK; Villani J; Freisthler B; Adams J; Aldridge A; Angerame A; Babineau DC; Bagley SM; Baker TJ; Balvanz P; Barbosa C; Barocas J; Battaglia TA; Beard DD; Beers D; Blevins D; Bove N; Bridden C; Brown JL; Bush HM; Bush JL; Caldwell R; Calver K; Calvert D; Campbell ANC; Carpenter J; Caspar R; Chassler D; Chaya J; Cheng DM; Cunningham CO; Dasgupta A; David JL; Davis A; Dean T; Drainoni ML; Eggleston B; Fanucchi LC; Feaster DJ; Fernandez S; Figueroa W; Freedman DA; Freeman PR; Freiermuth CE; Friedlander E; Gelberg KH; Gibson EB; Gilbert L; Glasgow L; Goddard-Eckrich DA; Gomori S; Gruss DE; Gulley J; Gutnick D; Hall ME; Harger Dykes N; Hargrove SL; Harlow K; Harris A; Harris D; Helme DW; Holloway J; Hotchkiss J; Huang T; Huerta TR; Hunt T; Hyder A; Ingram VL; Ingram T; Kauffman E; Kimball JL; Kinnard EN; Knott C; Knudsen HK; Konstan MW; Kosakowski S; Larochelle MR; Leaver HM; LeBaron PA; Lefebvre RC; Levin FR; Lewis N; Lewis N; Lofwall MR; Lounsbury DW; Luster JE; Lyons MS; Mack A; Marks KR; Marquesano S; Mauk R; McAlearney AS; McConnell K; McGladrey ML; McMullan J; Miles J; Munoz Lopez R; Nelson A; Neufeld JL; Newman L; Nguyen TQ; Nunes EV; Oller DA; Oser CB; Oyler DR; Pagnano S; Parran TV; Powell J; Powers K; Ralston W; Ramsey K; Rapkin BD; Reynolds JG; Roberts MF; Robertson W; Rock P; Rodgers E; Rodriguez S; Rudorf M; Ryan S; Salsberry P; Salvage M; Sabounchi N; Saucier M; Savitzky C; Schackman B; Schady E; Seiber EE; Shadwick A; Shoben A; Slater MD; Slavova S; Speer D; Sprunger J; Starbird LE; Staton M; Stein MD; Stevens-Watkins DJ; Stopka TJ; Sullivan A; Surratt HL; Sword Cruz R; Talbert JC; Taylor JL; Thompson KL; Vandergrift N; Vickers-Smith RA; Vietze DJ; Walker DM; Walley AY; Walters ST; Weiss R; Westgate PM; Wu E; Young AM; Zarkin GA; Walsh SL
    N Engl J Med; 2024 Jun; ():. PubMed ID: 38884347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for community-driven selection of strategies to implement evidence-based practices to reduce opioid overdoses in the HEALing Communities Study: a trial to evaluate a community-engaged intervention in Kentucky, Massachusetts, New York and Ohio.
    Young AM; Brown JL; Hunt T; Sprague Martinez LS; Chandler R; Oga E; Winhusen TJ; Baker T; Battaglia T; Bowers-Sword R; Button A; Fallin-Bennett A; Fanucchi L; Freeman P; Glasgow LM; Gulley J; Kendell C; Lofwall M; Lyons MS; Quinn M; Rapkin BD; Surratt HL; Walsh SL
    BMJ Open; 2022 Sep; 12(9):e059328. PubMed ID: 36123106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HEALing (Helping to End Addiction Long-term
    HEALing Communities Study Consortium
    Drug Alcohol Depend; 2020 Dec; 217():108335. PubMed ID: 33248391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Communities That HEAL Intervention on Buprenorphine-Waivered Practitioners and Buprenorphine Prescribing: A Prespecified Secondary Analysis of the HCS Randomized Clinical Trial.
    Stopka TJ; Babineau DC; Gibson EB; Knott CE; Cheng DM; Villani J; Wai JM; Blevins D; David JL; Goddard-Eckrich DA; Lofwall MR; Massatti R; DeFiore-Hyrmer J; Lyons MS; Fanucchi LC; Harris DR; Talbert J; Hammerslag L; Oller D; Balise RR; Feaster DJ; Soares W; Zarkin GA; Glasgow L; Oga E; McCarthy J; D'Costa L; Chahine R; Gomori S; Dalvi N; Shrestha S; Garner C; Shadwick A; Salsberry P; Konstan MW; Freisthler B; Winhusen J; El-Bassel N; Samet JH; Walsh SL
    JAMA Netw Open; 2024 Feb; 7(2):e240132. PubMed ID: 38386322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USA.
    Zang X; Walley AY; Chatterjee A; Kimmel SD; Morgan JR; Murphy SM; Linas BP; Nolen S; Reilly B; Urquhart C; Schackman BR; Marshall BDL
    Addiction; 2023 Dec; 118(12):2413-2423. PubMed ID: 37640687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community selected strategies to reduce opioid-related overdose deaths in the HEALing (Helping to End Addiction Long-term
    Chandler R; Nunes EV; Tan S; Freeman PR; Walley AY; Lofwall M; Oga E; Glasgow L; Brown JL; Fanucchi L; Beers D; Hunt T; Bowers-Sword R; Roeber C; Baker T; Winhusen TJ
    Drug Alcohol Depend; 2023 Apr; 245():109804. PubMed ID: 36780768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study.
    Winhusen T; Walley A; Fanucchi LC; Hunt T; Lyons M; Lofwall M; Brown JL; Freeman PR; Nunes E; Beers D; Saitz R; Stambaugh L; Oga EA; Herron N; Baker T; Cook CD; Roberts MF; Alford DP; Starrels JL; Chandler RK
    Drug Alcohol Depend; 2020 Dec; 217():108325. PubMed ID: 33091842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States.
    Chhatwal J; Mueller PP; Chen Q; Kulkarni N; Adee M; Zarkin G; LaRochelle MR; Knudsen AB; Barbosa C
    JAMA Netw Open; 2023 Jun; 6(6):e2314925. PubMed ID: 37294571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study.
    Irvine MA; Oller D; Boggis J; Bishop B; Coombs D; Wheeler E; Doe-Simkins M; Walley AY; Marshall BDL; Bratberg J; Green TC
    Lancet Public Health; 2022 Mar; 7(3):e210-e218. PubMed ID: 35151372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized clinical trial of a theory-based fentanyl overdose education and fentanyl test strip distribution intervention to reduce rates of opioid overdose: study protocol for a randomized controlled trial.
    Jacka BP; Goldman JE; Yedinak JL; Bernstein E; Hadland SE; Buxton JA; Sherman SG; Biello KB; Marshall BDL
    Trials; 2020 Nov; 21(1):976. PubMed ID: 33243291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study.
    Aldridge AP; Barbosa C; Barocas JA; Bush JL; Chhatwal J; Harlow KJ; Hyder A; Linas BP; McCollister KE; Morgan JR; Murphy SM; Savitzky C; Schackman BR; Seiber EE; E Starbird L; Villani J; Zarkin GA
    Drug Alcohol Depend; 2020 Dec; 217():108336. PubMed ID: 33152672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a "hub with many spokes" model.
    Knudsen HK; Freeman PR; Oyler DR; Oser CB; Walsh SL
    Addict Sci Clin Pract; 2023 Nov; 18(1):72. PubMed ID: 38031180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the Communities that HEAL intervention on receipt of behavioral therapies for opioid use disorder: A cluster randomized wait-list controlled trial.
    Glasgow L; Douglas C; Sprunger JG; Campbell ANC; Chandler R; Dasgupta A; Holloway J; Marks KR; Roberts SM; Martinez LS; Thompson K; Weiss RD; Aldridge A; Asman K; Barbosa C; Blevins D; Chassler D; Cogan L; Fanucchi L; Hall ME; Hunt T; Jadovich E; Levin FR; Lincourt P; Lofwall MR; Loukas V; McAlearney AS; Nunes E; Oga E; Oller D; Rudorf M; Sullivan AM; Talbert J; Taylor A; Teater J; Vandergrift N; Woodlock K; Zarkin GA; Freisthler B; Samet JH; Walsh SL; El-Bassel N
    Drug Alcohol Depend; 2024 Jun; 259():111286. PubMed ID: 38626553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community dashboards to support data-informed decision-making in the HEALing communities study.
    Wu E; Villani J; Davis A; Fareed N; Harris DR; Huerta TR; LaRochelle MR; Miller CC; Oga EA
    Drug Alcohol Depend; 2020 Dec; 217():108331. PubMed ID: 33070058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operationalizing and selecting outcome measures for the HEALing Communities Study.
    Slavova S; LaRochelle MR; Root ED; Feaster DJ; Villani J; Knott CE; Talbert J; Mack A; Crane D; Bernson D; Booth A; Walsh SL
    Drug Alcohol Depend; 2020 Dec; 217():108328. PubMed ID: 33091844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.
    Walley AY; Xuan Z; Hackman HH; Quinn E; Doe-Simkins M; Sorensen-Alawad A; Ruiz S; Ozonoff A
    BMJ; 2013 Jan; 346():f174. PubMed ID: 23372174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island.
    Zang X; Macmadu A; Krieger MS; Behrends CN; Green TC; Morgan JR; Murphy SM; Nolen S; Walley AY; Schackman BR; Marshall BD
    Int J Drug Policy; 2021 Dec; 98():103435. PubMed ID: 34482264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of model-based vs. permutation tests in the HEALing (Helping to End Addiction Long-term
    Tang X; Heeren T; Westgate PM; Feaster DJ; Fernandez SA; Vandergrift N; Cheng DM
    Trials; 2022 Sep; 23(1):762. PubMed ID: 36076295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.